Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Stifel analysts took a cautious stance on IPG Photonics (NASDAQ:IPGP), revising the company's price target downward to $85 from the previous target of $100. Despite the reduction, Stifel continues to ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

Stifel Financial (SF) announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth Tracker app. The ...

GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...

On January 31, Stifel reduced Intel’s price target from $25 to $21 while maintaining a Hold rating. The firm noted that ...

Tesla (NASDAQ:TSLA – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $492.00 to ...

Sintavia, LLC, the world’s leading all-digital aerospace component manufacturer, announced today that it has received a $10 million subordinated debt investment from the Stifel North Atlantic ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...